Adult population Maxolon is indicated in adults for: - Prevention of delayed chemotherapy induced nausea and vomiting (CINV) - Prevention of radiotherapy induced nausea and vomiting (RINV). - Symptomatic treatment of nausea and vomiting, including acute migraine induced nausea and vomiting. Metoclopramide can be used in combination with oral analgesics to improve the absorption of analgesics in acute migraine. Diagnostic procedures : Radiology, Duodenal intubation 'Maxolon' speeds up the passage of a barium meal by increasing the rate of gastric emptying, co-ordinating peristalsis and dilating the duodenal bulb. 'Maxolon' also facilitates duodenal intubation procedures. Paediatric population Maxolon is indicated in children (aged 1-18 years) for: - Prevention of delayed chemotherapy induced nausea and vomiting (CINV) as a second line option
Adult population: Metoclopramide is indicated in adults for: - Prevention of post operative nausea and vomiting (PONV) - Symptomatic treatment of nausea and vomiting, including acute migraine induced nausea and vomiting - Prevention or treatment of nausea and vomiting (feeling or being sick), including nausea and vomiting that may result from anticancer medicines (CINV) or radiation treatment (RINV) Paediatric population Metoclopramide is indicated in children (aged 1-18 years) for: - Prevention of delayed chemotherapy induced nausea and vomiting (CINV) as a second line option - Treatment of post operative nausea and vomiting (PONV) as a second line option. This medication should not be used in children under 1 year old. For other indications, the use in the paediatric population is not recommended.
The FDA has given approval for the Abbreviated New Drug Application (ANDA) for acetylcysteine injection, from APP Pharma, indicated to...
Basilea Pharmaceutica Ltd, a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced that the FDA approved Zevtera (ceftobiprole medocaril sodium for injection), for the treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis, and adult patients with acute bacterial skin and skin structure infections (ABSSSI) and for adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP)
Kaleo (formerly Intelliject) announced that the FDA has approved Evzio (naloxone hydrochloride injection) for the emergency treatment of known or...
Mylan N.V. announced that the FDA has approved Mylan's Abbreviated New Drug Applications (ANDAs) for Glatiramer Acetate Injection 40 mg/mL...
Apellis Pharmaceuticals, Inc. provided an update on injection kits supplied by Apellis and an update on the rare events of retinal vasculitis reported in real-world treatment with Synfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
Amgen announced the submission of an application to the FDA seeking approval of a single-dosing option for the monthly administration...
Eton Pharmaceuticals, Inc announced the FDA has accepted for filing the company’s new drug application (NDA) for dehydrated alcohol injection (DS 100).